Chaim Linhart, Chaim, Co-founder and CTO at Ibex Medical Analytics
Artificial intelligence (AI) technology is set to transform the field of diagnostics, similar to how X-rays and genetic tests revolutionized healthcare in the past. Reshaping…
Continue Reading
Lunit’s acquisition of Volpara at AUD 1.15 per share marks a pivotal move in cancer diagnostics. The Scheme Implementation Agreement targets Volpara’s AI-enabled solutions, expanding Lunit’s global presence. Volpara’s 100 million mammogram images promise…
Continue Reading
What You Should Know:
– Absci Corporation (ABSI), a pioneer in using generative AI to discover antibodies, and AstraZeneca, a global biopharmaceutical leader, announced a collaboration today to develop an AI-designed antibody for cancer.
– This…
Continue Reading
What You Should Know:
– Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has partnered with NTT DATA Singapore to introduce Lunit INSIGHT CXR at Singapore General Hospital (SGH) and Changi General…
Continue Reading
Ibex Logo
What You Should Know:
– Dedalus Group, an anatomic pathology information systems provider in Europe, and Ibex Medical Analytics, a market leader in AI-powered cancer diagnostics, have jointly launched an integrated End-to-End AI-powered Digital…
Continue Reading
Healthcare AI startup Paige is joining forces with Microsoft subsidiary Nuance to launch what they say is “the largest digital consultation network in pathology,” the companies announced Monday at RSNA 2023, the annual radiology…
Continue Reading
Shareholders of KOSDAQ-listed Lunit have recently participated in the company’s recent capital raise, paying-in $150 million to fund its development of “next-generation” products and further expansion in the West. Meanwhile, the AI cancer diagnostics solutions…
Continue Reading
GE HealthCare partners with BAMF Health to propel theranostics adoption, amplifying precision medicine in the U.S. This alliance harnesses cutting-edge imaging technology and therapeutic agents to target cancer cells precisely. The collaboration spans technology…
Continue Reading
At RSNA 2023, Lunit will display seven AI studies aimed at enhancing diagnostic efficiency in chest radiography and breast cancer risk evaluation. The presentations will showcase advancements like AI algorithms that improve the accuracy…
Continue Reading
Dr. Robert Bard, a leader in radiological diagnostics, advocates for 3D Doppler imaging’s role in non-invasive cancer detection, particularly in breast, prostate, and skin cancers. Highlighting its precision and the reduced need for biopsies,…
Continue Reading
